Ritu Baral
Stock Analyst at TD Cowen
(3.67)
# 805
Out of 5,130 analysts
46
Total ratings
52.63%
Success rate
8.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Maintains: Buy | $202 → $306 | $261.41 | +17.06% | 1 | Jan 9, 2026 | |
| VTVT vTv Therapeutics | Initiates: Buy | $67 | $35.58 | +88.33% | 1 | Jan 5, 2026 | |
| INSM Insmed | Maintains: Buy | $269 → $241 | $175.97 | +36.96% | 7 | Dec 18, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $97 → $133 | $92.41 | +43.92% | 3 | Dec 16, 2025 | |
| MIST Milestone Pharmaceuticals | Upgrades: Buy | $8 | $2.04 | +292.16% | 1 | Dec 15, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $251 → $353 | $288.45 | +22.38% | 1 | Dec 8, 2025 | |
| VERA Vera Therapeutics | Maintains: Buy | $60 → $73 | $48.71 | +49.87% | 2 | Dec 5, 2025 | |
| RNA Avidity Biosciences | Downgrades: Hold | $78 → $74 | $72.37 | +2.25% | 2 | Oct 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $35 → $39 | $26.78 | +45.63% | 2 | Sep 11, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $390 → $554 | $514.06 | +7.77% | 2 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.55 | - | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.30 | - | 2 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $282 → $371 | $398.29 | -6.85% | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.21 | - | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $175 | $23.83 | +634.37% | 1 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $79.99 | - | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $0.71 | - | 1 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $15.01 | - | 1 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.75 | - | 2 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $35.48 | - | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.32 | - | 1 | Jun 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.49 | - | 2 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $631.69 | - | 2 | Jan 12, 2018 |
Krystal Biotech
Jan 9, 2026
Maintains: Buy
Price Target: $202 → $306
Current: $261.41
Upside: +17.06%
vTv Therapeutics
Jan 5, 2026
Initiates: Buy
Price Target: $67
Current: $35.58
Upside: +88.33%
Insmed
Dec 18, 2025
Maintains: Buy
Price Target: $269 → $241
Current: $175.97
Upside: +36.96%
Palvella Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $97 → $133
Current: $92.41
Upside: +43.92%
Milestone Pharmaceuticals
Dec 15, 2025
Upgrades: Buy
Price Target: $8
Current: $2.04
Upside: +292.16%
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $251 → $353
Current: $288.45
Upside: +22.38%
Vera Therapeutics
Dec 5, 2025
Maintains: Buy
Price Target: $60 → $73
Current: $48.71
Upside: +49.87%
Avidity Biosciences
Oct 29, 2025
Downgrades: Hold
Price Target: $78 → $74
Current: $72.37
Upside: +2.25%
ACADIA Pharmaceuticals
Sep 11, 2025
Maintains: Buy
Price Target: $35 → $39
Current: $26.78
Upside: +45.63%
Madrigal Pharmaceuticals
Aug 26, 2025
Maintains: Buy
Price Target: $390 → $554
Current: $514.06
Upside: +7.77%
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.55
Upside: -
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.30
Upside: -
Oct 21, 2024
Maintains: Buy
Price Target: $282 → $371
Current: $398.29
Upside: -6.85%
Aug 8, 2023
Initiates: Outperform
Price Target: n/a
Current: $6.21
Upside: -
Mar 22, 2023
Maintains: Outperform
Price Target: $125 → $175
Current: $23.83
Upside: +634.37%
Nov 23, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $79.99
Upside: -
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.71
Upside: -
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $15.01
Upside: -
Jul 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.75
Upside: -
Mar 2, 2021
Initiates: Outperform
Price Target: n/a
Current: $35.48
Upside: -
Jun 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.32
Upside: -
Jul 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $0.49
Upside: -
Jan 12, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $631.69
Upside: -